January 31, 2018
Sanofi asks EMA to review drug for sleeping sickness
Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being…
On World Sleep Day, sleep experts encourage people to understand the value of healthy and solid sleep. Interrupted sleep is associated with significant health problems, both physical and psychological, including obesity, diabetes, cancer, depression and anxiety.